|
Originally published In Press as doi:10.1074/jbc.M304489200 on August 28, 2003
J. Biol. Chem., Vol. 278, Issue 45, 44857-44867, November 7, 2003
Identification of the Downstream Targets of SIM1 and ARNT2, a Pair of Transcription Factors Essential for Neuroendocrine Cell Differentiation*
Chunqiao Liu,
Eleni Goshu,
Aynslee Wells, and
Chen-Ming Fan
From the
Department of Embryology, Carnegie Institution of Washington, Baltimore, Maryland 21210
SIM1 and ARNT2 are two basic helix-loop-helix/PAS (Per-Arnt-Sim) transcription factors that control the differentiation of neuroendocrine lineages in the mouse hypothalamus. Heterozygous Sim1 mice also develop early onset obesity, possibly due to hypodevelopment of the hypothalamus. Although SIM1 and ARNT2 form heterodimers to direct the same molecular pathway, knowledge of this pathway is limited. To facilitate the identification of their downstream genes, we combined an inducible gene expression system in a neuronal cell line with microarray analysis to screen for their transcriptional targets. This method identified 268 potential target genes of SIM1/ARNT2 that displayed >1.7-fold induced expression. 15 of these genes were subjected to Northern analysis, and a high percentage of them were confirmed to be up-regulated. In vivo, several of these genes showed neuroendocrine hypothalamic expression correlating with that of Sim1. Furthermore, we found that expression of two of these potential targets, the Jak2 and thyroid hormone receptor 2 genes, was lost in the neuroendocrine hypothalamus of the Sim1 mutant. The expression and predicted functions of many of these genes provide new insight into both the Sim1/Arnt2 action in neuroendocrine hypothalamus development and the molecular basis for the Sim1 haplo-insufficient obesity phenotype.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 1. A, schematic representation of the plasmids used in this study: pTRE2hyg, empty vector without a cDNA insert used as a control; pTRE-SF, pTRE2hyg harboring full-length Sim1 and Arnt2 joined by the IRES; pTRE-SN-Gal4, pTRE2hyg harboring the Sim1 N-terminal bHLH/PAS domain (SimN) fused to the Gal4 activation domain, IRES, and Arnt2; pTRE-SN-VP16, pTRE2hyg harboring SimN fused to the VP16 activation domain, IRES, and Arnt2; pTRE-Arnt2 and pTRESim-VP16, pTRE2hyg harboring Arnt2 and SimN fused to VP16, respectively; pTet-On, for expression of the tetracycline-controlled transactivator rtTA; pTet-tTS, for expression of the tetracycline-controlled silencer tTS; pML/6C-WT (17), a luciferase reporter driven by the adenovirus major late promoter linked to four copies of CME (4xCME) for SIM1/ARNT2 binding; pML/6C-AM (17), a similar reporter linked to four copies of CME with point mutations (CMEm) as shown. TRE, tetracycline-responsive element for rTA and tTS binding; PCMV, cytomegalovirus-derived enhancer/promoter for high level transcription; PminCMV, minimal cytomegalovirus-derived enhancer/promoter. B, comparison of the activities of SIM1 variants in the Tet-On system. Transient transfections of the Neuro-2a cells were carried out using the plasmids indicated. The fold induction was calculated as relative luciferase activities of the doxycycline-treated (Dox+) over the mock-treated (Dox-) samples. The relative luciferase activities were normalized to the -galactosidase activity from cotransfected pSV- gal (data not shown). Results represent the mean of three independent experiments, and the error bars are the S.D. values. C, activation of the reporter by the SimN-VP16 fusion gene depends on Arnt2 expression from either a separate plasmid or a single plasmid linked by IRES and the wild-type CME, but not the mutant CME. Transfections, luciferase measurement, and normalization were the same as described for B. Arbitrary luciferase values were used to indicate CME activation.
|
|
Received for publication, April 29, 2003
, and in revised form, August 21, 2003.
* This work was supported by National Institutes of Health Grant RO1HD35596 (to C.-M. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org)contains Supplemental Fig. 1.
To whom correspondence should be addressed: Dept. of Embryology, Carnegie Institution of Washington, 115 W. University Pkwy., Baltimore, MD 21210. Tel.: 410-554-1222; Fax: 410-243-6311; E-mail: fan{at}ciwemb.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Balbir, H. Lee, M. Okumura, S. Biswal, R. S. Fitzgerald, and M. Shirahata
A search for genes that may confer divergent morphology and function in the carotid body between two strains of mice
Am J Physiol Lung Cell Mol Physiol,
March 1, 2007;
292(3):
L704 - L715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Allan and D. H. Sherr
Constitutive Activation and Environmental Chemical Induction of the Aryl Hydrocarbon Receptor/Transcription Factor in Activated Human B Lymphocytes
Mol. Pharmacol.,
May 1, 2005;
67(5):
1740 - 1750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Freeburg and D. R. Abrahamson
Divergent Expression Patterns for Hypoxia-Inducible Factor-1{beta} and Aryl Hydrocarbon Receptor Nuclear Transporter-2 in Developing Kidney
J. Am. Soc. Nephrol.,
October 1, 2004;
15(10):
2569 - 2578.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|